BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32882157)

  • 1. Immunization status and re-immunization of childhood acute lymphoblastic leukemia survivors.
    Toret E; Yel SE; Suman M; Duzenli Kar Y; Ozdemir ZC; Dinleyici M; Bor O
    Hum Vaccin Immunother; 2021 Apr; 17(4):1132-1135. PubMed ID: 32882157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles, mumps, and rubella antibody status and response to immunization in children after therapy for acute lymphoblastic leukemia.
    Aytac S; Yalcin SS; Cetin M; Yetgin S; Gumruk F; Tuncer M; Yurdakok K; Gurgey A
    Pediatr Hematol Oncol; 2010 Aug; 27(5):333-43. PubMed ID: 20469978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens.
    Nilsson A; De Milito A; Engström P; Nordin M; Narita M; Grillner L; Chiodi F; Björk O
    Pediatrics; 2002 Jun; 109(6):e91. PubMed ID: 12042585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential loss of humoral immunity against measles, mumps, rubella and varicella-zoster virus in children treated for cancer.
    Bochennek K; Allwinn R; Langer R; Becker M; Keppler OT; Klingebiel T; Lehrnbecher T
    Vaccine; 2014 Jun; 32(27):3357-61. PubMed ID: 24793952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody waning after immunosuppressive chemotherapy and immunomodulators, re-immunization considerations in pediatric patients with malignancy and chronic immune thrombocytopenic purpura.
    Abdolkarimi B; Amanati A; Molavi Vardanjani H; Jamshidi S; Tabaeian SAP
    BMC Infect Dis; 2022 Jul; 22(1):657. PubMed ID: 35902837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
    Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S
    Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral immune response of childhood acute lymphoblastic leukemia survivors against the measles, mumps, and rubella vaccination.
    Fouda AE; Kandil SM; Boujettif F; Salama YS; Fayea NY
    Hematology; 2018 Oct; 23(9):590-595. PubMed ID: 29614919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catch-up vaccination and enhanced immunization against hepatitis B, hepatitis A, measles, mumps, rubella and varicella in children with idiopathic thrombocytopenic purpura.
    Taşar S; Taşar MA; Saç RÜ; Alioğlu B
    J Trop Pediatr; 2023 Aug; 69(4):. PubMed ID: 37648424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
    Johnson CE; Kumar ML; Whitwell JK; Staehle BO; Rome LP; Dinakar C; Hurni W; Nalin DR
    Pediatr Infect Dis J; 1996 Aug; 15(8):687-92. PubMed ID: 8858673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R; Rahman MM; Hassan Z; Hassan MS
    Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.
    Kontio M; Palmu AA; Syrjänen RK; Lahdenkari M; Ruokokoski E; Davidkin I; Vaarala O; Melin M
    J Infect Dis; 2016 Jun; 213(12):2005-13. PubMed ID: 26908733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of immune response following immunization with DTP/Td and MMR vaccines in children treated for acute lymphoblastic leukemia.
    Koochakzadeh L; Khosravi MH; Pourakbari B; Hosseinverdi S; Aghamohammadi A; Rezaei N
    Pediatr Hematol Oncol; 2014 Oct; 31(7):656-63. PubMed ID: 25007393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubella vaccination in children treated for acute lymphoblastic leukemia.
    Ercan TE; Soycan LY; Apak H; Celkan T; Ozkan A; Akdenizli E; Kasapçopur O; Yildiz I
    J Pediatr Hematol Oncol; 2005 May; 27(5):273-7. PubMed ID: 15891564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study].
    He HQ; Li Q; Yan R; Zhou Y; Tang XW; Deng X; Xie SY; Chen ZP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr; 51(4):336-340. PubMed ID: 28395468
    [No Abstract]   [Full Text] [Related]  

  • 15. Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants.
    D'Angio CT; Boohene PA; Mowrer A; Audet S; Menegus MA; Schmid DS; Beeler JA
    Pediatrics; 2007 Mar; 119(3):e574-9. PubMed ID: 17332177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term immunogenicity of measles, mumps and rubella-containing vaccines in healthy young children: A 10-year follow-up.
    Carryn S; Feyssaguet M; Povey M; Di Paolo E
    Vaccine; 2019 Aug; 37(36):5323-5331. PubMed ID: 31345639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of maternal measles, rubella, mumps and varicella antibodies in the first six months of life].
    Devecioğlu E; Gökçay G; Boran P; Eren T; Yılmaz G; Badur S
    Mikrobiyol Bul; 2018 Jul; 52(3):324-327. PubMed ID: 30156519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decline in rates of seropositivity for measles, mumps, and rubella antibodies among previously immunized children treated for acute leukemia.
    Feldman S; Andrew M; Norris M; McIntyre B; Iyer R
    Clin Infect Dis; 1998 Aug; 27(2):388-90. PubMed ID: 9709893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to measles, mumps, and rubella virus in Thai children after two-dose vaccination at 9 months and 2.5 years: A longitudinal study.
    Wanlapakorn N; Puenpa J; Thongmee T; Srimuan D; Thatsanathorn T; Vongpunsawad S; Poovorawan Y
    Vaccine; 2020 May; 38(24):4016-4023. PubMed ID: 32331806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to measles-mumps-rubella vaccine in children on dialysis.
    Schulman SL; Deforest A; Kaiser BA; Polinsky MS; Baluarte HJ
    Pediatr Nephrol; 1992 Mar; 6(2):187-9. PubMed ID: 1571219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.